Across the centuries, arcs have defined architecture, design, and now… glaucoma care?
At ESCRS 2025 in Copenhagen, Glaukos reveals the iStent infinite® Trabecular Micro-Bypass: a breakthrough in glaucoma care with three stents preloaded in one new next-generation injector, designed to occupy just 3% of Schlemm’s canal while creating up to 240° of sustained outflow. For moderate to advanced glaucoma, it’s more than a procedure, it’s a revolution.
Visit Booth #E154 to find out more.
Stent infinite® IMPORTANT SAFETY INFORMATION: https://glaukos.showpad.com/share/whEAZgd28rRkhzQOJYyrg
Glaukos® and iStent infinite® are registered trademarks of Glaukos Corporation.
All rights reserved. ©2025. PM-EU-0379
This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all countries.
